Biotechnology and Pharmaceuticals sector

An Expert's View about Biotechnology in India

Posted on: 29 Aug 2012

The recent developments in the Biotechnology & Pharmaceutical sector in India and Indian government initiatives indicate increasing business opportunities.

Biotechnology and Pharmaceuticals sector in India India is fast emerging as an important player in the biotechnology sector in the Asia–Pacific Region. Market overview The large pool of scientific talent available at a reasonable cost, a wealth of R & D institutions, a rich and varied bio-diversity, a flourishing pharmaceutical industry, strong IT skills and an English speaking population have all placed India favourably in the global market The recent developments in the Biotechnology & Pharmaceutical sector in India and Indian government initiatives indicate increasing business opportunities for the UK’s Biotechnology & Pharmaceutical sector Investments, along with outsourcing activities and exports, are key drivers for growth in the biotech sector.FDI up to 100% is permitted through the automatic route for manufacturers of drugs and pharmaceuticals ξ India is recognised as a mega bio-diversity country. Biotechnology in India offers opportunities to convert the biological resources into economic wealth and employment opportunities. India is a Bio Based economy perusing innovative products and services using efficient renewable resources. ξ The Indian Biotechnology industry registered an 18.5% growth recording INR 20,440.7 Crore in revenue in 2011-2012. During the last five years, the Indian biotech industry has recorded CAGR of 14.75% ξ The Indian Pharmaceutical industry has grown at 15.7% (December 2011). Globally India ranks 3rd in terms of manufacturing pharma products by volume. The Indian Pharmaceutical Industry is expected to grow at 9.5% till 2015 ξ BioPharma, BioServices and BioAgri are subsectors with the highest growth with 19%, 15.50% and 23.00% respectively. Some of the other subsectors in Biotech industry are BioIndustrial and BioInformatics ξ Most important clusters for Biotechnology & Pharmaceuticals are Bangalore in Karnataka (South), Mumbai in Maharashtra and Ahmedabad in Gujarat (Western), Hyderabad in Andhra Pradesh (South) and Chennai in Tamil Nadu (South) ξ Pharma and Biotech Industry is clustered in Western and Southern India with 44% and 40.7% market share respectively. Western India is the manufacturing hub and Southern India is the R&D hub of the sector. Key opportunities Opportunities for UK companies in Biotechnology and Pharmaceuticals sector in India : ξ Harnessing University talent for research & development to marketing activities to bridge gap in the skills requirements of the industry ξ UK’s scientific expertise pool, incubation centres with seed funding to develop ideas to innovation ξ Partnering with Indian companies for co-production or co- development of drugs and drug entities, platform technologies and BioPharma services. Indian companies are looking at joint ventures in developing niche areas of biosimilars ξ Partnering with the UK companies in the field of Clinical research to provide better regulatory infrastructure, bio-manufacturing standards, clinical development capabilities, R & D collaborations, pre-clinical development ξ Marketing and distribution services for niche products by UK companies into Indian market ξ Licensing & Distribution of drugs and pharmaceutical components ξ Working with the Indian regulatory framework by adding to the policies and guidelines in certain subsectors of Lifescience like Stem Cells and regenerative medicine. Supporting public, private associations in their policies would help in showcasing the strengths of UK regulatory framework Latest export opportunities – Biotechnology & Pharmaceuticals Latest export opportunities – India Getting into the market UK Lifescience companies can enter the Indian Market by: ξ Partnering with local companies for co-development, distribution and sales of products and services ξ Visiting the companies in the local market and following up on operations and distributor activities in the local market ξ Following India’s regulatory norms and submitting required paperwork for approval of pharmaceutical and biotechnology products developed and marketed here ξ Working with UKTI on market research and introduction to key decision makers in India ξ Working with UKTI on developing an India strategy and the market entry strategy. More about doing business in India Contacts Market intelligence is critical when doing business overseas, and UKTI can provide bespoke market research and support during overseas visits though our chargeable Overseas Market Introduction Service (OMIS). To commission research or for general advice about the market, get in touch with our specialists in country - or contact your local international trade team. ξ Priya Varadarajan, British Deputy High Commission, Bangalore, Tel: +91 80 22100200; ξ Namrata Devalla, British Deputy High Commission, Bangalore. Tel: +91 80 22100200; Contact your local international trade team Events UKTI runs a range of events for exporters, including seminars in the UK, tra ξ BIO India- International Conference, Mumbai: 12-13 September2012 ξ CPhI India Conference, Mumbai: 21-23 November 2012 ξ ISCR Annual Conference, Mumbai: January 2013 ξ Bangalore India Bio 2013, Bangalore: 4-6 February 2013 de missions to overseas markets and support for attendance at overseas trade shows. Latest events – Biotechnology & Pharmaceuticals Useful links More about OMIS and other UKTI services for exporters
Posted: 29 August 2012

See more from Biotechnology in India

Expert Views    
Biotechnology and Pharmaceutical Opportunities in India   By UK Trade & Investment
Biotechnology and Pharmaceuticals sector   By UK Trade & Investment
Developments in the Indian BioPharma Industry   By UK Trade & Investment
Opportunities in the Indian BioPharma Industry   By UK Trade & Investment
Presenting the contributor